SomaLogic Issues Statement Correcting Madryn Asset Management's Misleading Disclosure

SomaLogic Publishes Key Correspondence from LabCorp CEO Omitted by Madryn in its Attempt to Undermine Confidence in SomaLogic's Thorough Strategic Process
Reiterates Value-Maximizing Transaction...

Related Keywords

New York ,United States ,Adam Schechter ,Adam Taich ,Marissa Bych ,Wilkinson Brimmer Katcher ,Ruben Gutierrez ,Troy Cox ,Garheng Kong ,Joele Frank ,Tom Carey ,Jason Ryan ,Lyle Weston Carly King ,Avinash Amin ,Adam Schecter ,Morrow Sodali ,Standard Biotool Investor Relations Department ,Linkedin ,Institutional Shareholder Services ,Nasdaq ,Somalogic Inc ,Exchange Commission ,Gilmartin Group ,Somalogic Publishes Key Correspondence ,Undermine Confidence ,Thorough Strategic ,Value Maximizing Transaction ,Standard Biotools ,Best Interests ,All Stockholders ,Madryn Asset Management ,Christmas Eve ,Managing Director ,Lead Independent Director ,Madryn Capital Management ,Somalogic Board ,Tycho Peterson ,Ethan Skerry ,External Email ,Asset Management ,Special Meeting ,Standard Biotool ,Standard Biotool Investor Relations ,Somalogic Investor Relations ,Current Reports ,Securities Act ,Private Securities Litigation Reform Act ,Wilkinson Brimmer ,Markets ,